Navigation Links
Fischer Medical Announces Multi-System VersaRad Installation at St. Joseph's Hospital in Marshfield, WI
Date:3/18/2009

DENVER, March 18 /PRNewswire/ -- St. Joseph's Hospital in Marshfield, WI has completed the multi-unit installation of Fischer Medical Technologies' VersaRad CR radiography system. These units are being used in the Emergency/Trauma Department as well as for St. Joe's Diagnostic Imaging services.

St. Joseph's Hospital and Marshfield Clinic are the principal organizations of the Marshfield medical complex serving Wisconsin and the Upper Peninsula of Michigan. The Clinic, which adjoins the Hospital, is one of the country's largest private multispecialty group practices, with more than 700 physician-specialists.

Scott Lokken, Radiology Manager at St. Joseph's, worked directly with Fischer to customize the VersaRad units, making them precisely suitable for the current radiography needs of the hospital and clinic, yet adaptable for future growth and advancements in technology. Lokken's past experience with Fischer's predecessor Traumex system is the basis on which he chose the VersaRad CR. In particular, he cites that with this system virtually all radiographic procedures can be performed in both the ER and general radiographic rooms; rooms needed to be available for use 24/7 and provide high throughput. This enables his facility to perform as many as 60 procedures during a 12-hour shift.

The VersaRad's unique design is durable, easy to use, and very importantly cost-effective - all of which will contribute to St. Joe's ability to meet its medical and business objectives.

Morgan W. Nields, Chairman and CEO of Fischer Medical Technologies indicated that Fischer is about to release the VersaRad DR, a digital radiographic system affordably upgradeable from the CR units purchased by St. Joe's. Nields explained, "Fischer had installed hundreds of Traumex systems throughout the US and Europe since its first version was developed in the 1980's. We are pleased that we are able to offer our customers an opportunity to economically trade or upgrade the original systems to the latest CR or DR VersaRad."

ABOUT FISCHER MEDICAL TECHNOLOGIES

Fischer Medical Technologies Inc. designs, manufactures and markets medical technology in the general radiography, electrophysiology, and surgical imaging systems arenas. Fischer's roots go back to 1910, when H.G. Fischer, the oldest manufacturer of X-ray imaging devices in the United States, began its operation in Chicago, IL. Since then, the reputation and name of the company have evolved and gained worldwide recognition by leveraging technology that has brought to market such innovations as the Traumex (VersaRad), the Bloom DTU-215 Stimulator, Electrophysiology imaging systems, and the Mammotest breast biopsy system.

For more information, visit http://www.FischerMTI.com

    Contact:

    Kent Kruse, Vice President of Sales
    1-800-777-5345

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Fischer Medical Technologies Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Visions Medical Advisory Board Voices Support for Current Management
2. Microwize to Hold Free Stimulus Package Workshop for Medical Industry
3. Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam
4. Materials for Medical Devices Database Reaches Milestone
5. Foundation for Biomedical Research Releases Groundbreaking PSA
6. 1 in 4 Americans lacks timely access to optimal care during time-sensitive medical emergencies
7. Medical Costs for One Premature Baby Could Cover a Dozen Healthy Births
8. PHT to Demonstrate Innovative Medical Payment Solution at HIMSS Conference
9. National Hispanic Medical Association Conference in NYC Focuses on Increasing the Latino Health Care Workforce
10. Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act
11. Cantel Medical Corp. to Present at the 13th Annual Sidoti & Company Emerging Growth Institutional Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... serving San Francisco and environs, is proud to announce an upgrade to the ... on the upgraded Yelp page on topics as diverse as Platelet Rich Plasma ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based ... and Palo Alto, is proud to announce an important upgrade to its geographic information ... home care close to home, and by having city-specific pages, NuevaCare is answering that ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... In the Health Care IT campaign, Robert Herjavec discusses health IT security ... will be attacked, but when.” However, he and many others involved highlight a promising ... in auditing and monitoring have taken security in health care a very long way. ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  Interpace Diagnostics Group, ... provides clinically useful molecular diagnostic tests and pathology services, ... presented at the upcoming United States ... held March 4-10, 2017 in San Antonio, ... a review of data from the Company,s extensive experience ...
(Date:2/27/2017)... Fla. , Feb. 27, 2017 ... focused on developing cerebral embolic protection devices for ... the FDA,s Circulatory System Devices Panel that convened ... need for cerebral protection following transcatheter aortic valve ... by this FDA panel support the need for ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
Breaking Medicine Technology: